These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 12909611)
1. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action. Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Mandarino LJ J Appl Physiol (1985); 2003 Dec; 95(6):2519-29. PubMed ID: 12909611 [TBL] [Abstract][Full Text] [Related]
2. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Kashyap S; Mandarino LJ Metabolism; 2004 Sep; 53(9):1233-42. PubMed ID: 15334390 [TBL] [Abstract][Full Text] [Related]
3. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Vestergaard H Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651 [TBL] [Abstract][Full Text] [Related]
4. Effects of exercise and insulin on insulin signaling proteins in human skeletal muscle. Koval JA; Maezono K; Patti ME; Pendergrass M; DeFronzo RA; Mandarino LJ Med Sci Sports Exerc; 1999 Jul; 31(7):998-1004. PubMed ID: 10416561 [TBL] [Abstract][Full Text] [Related]
5. Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle. Liu Z; Wu Y; Nicklas EW; Jahn LA; Price WJ; Barrett EJ Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E523-8. PubMed ID: 14656717 [TBL] [Abstract][Full Text] [Related]
6. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725 [TBL] [Abstract][Full Text] [Related]
7. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626 [TBL] [Abstract][Full Text] [Related]
8. Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation. Nikoulina SE; Ciaraldi TP; Carter L; Mudaliar S; Park KS; Henry RR J Clin Endocrinol Metab; 2001 Sep; 86(9):4307-14. PubMed ID: 11549666 [TBL] [Abstract][Full Text] [Related]
9. Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology. Bak JF Dan Med Bull; 1994 Apr; 41(2):179-92. PubMed ID: 8039433 [TBL] [Abstract][Full Text] [Related]
10. Decreased insulin action in skeletal muscle from patients with McArdle's disease. Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356 [TBL] [Abstract][Full Text] [Related]
11. Insulin-stimulated insulin receptor substrate-2-associated phosphatidylinositol 3-kinase activity is enhanced in human skeletal muscle after exercise. Howlett KF; Sakamoto K; Yu H; Goodyear LJ; Hargreaves M Metabolism; 2006 Aug; 55(8):1046-52. PubMed ID: 16839840 [TBL] [Abstract][Full Text] [Related]
12. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Thong FS; Derave W; Kiens B; Graham TE; Ursø B; Wojtaszewski JF; Hansen BF; Richter EA Diabetes; 2002 Mar; 51(3):583-90. PubMed ID: 11872654 [TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal. Yokoyama H; Emoto M; Mori K; Araki T; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y J Clin Endocrinol Metab; 2006 Jan; 91(1):290-4. PubMed ID: 16234307 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes. Pedersen AJ; Hingst JR; Friedrichsen M; Kristensen JM; Højlund K; Wojtaszewski JF Diabetologia; 2015 Jul; 58(7):1569-78. PubMed ID: 25870023 [TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients. Miyazaki Y; He H; Mandarino LJ; DeFronzo RA Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909 [TBL] [Abstract][Full Text] [Related]
17. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943 [TBL] [Abstract][Full Text] [Related]
18. Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Frøsig C; Rose AJ; Treebak JT; Kiens B; Richter EA; Wojtaszewski JF Diabetes; 2007 Aug; 56(8):2093-102. PubMed ID: 17513702 [TBL] [Abstract][Full Text] [Related]
19. Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Vind BF; Pehmøller C; Treebak JT; Birk JB; Hey-Mogensen M; Beck-Nielsen H; Zierath JR; Wojtaszewski JF; Højlund K Diabetologia; 2011 Jan; 54(1):157-67. PubMed ID: 20938636 [TBL] [Abstract][Full Text] [Related]
20. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]